Literature DB >> 27165635

Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

M K Larsson1, A Faka1, M Bhat2, S Imbeault1, M Goiny1, F Orhan1, A Oliveros3, S Ståhl4, X C Liu1, D S Choi3,5,6, K Sandberg1,3,7, G Engberg1, L Schwieler1, S Erhardt8.   

Abstract

The immune system has been recognized as a potential contributor to psychiatric disorders. In animals, lipopolysaccharide (LPS) is used to induce inflammation and behaviors analogous to some of the symptoms in these disorders. Recent data indicate that the kynurenine pathway contributes to LPS-induced aberrant behaviors. However, data are inconclusive regarding optimal LPS dose and treatment strategy. Here, we therefore aimed to evaluate the effects of single versus repeated administration of LPS on the kynurenine pathway. Adult C57BL6 mice were given 0.83 mg/kg LPS as a single or a repeated injection (LPS + LPS) and sacrificed after 24, 48, 72, or 120 h. Mice receiving LPS + LPS had significantly elevated brain kynurenine levels at 24 and 48 h, and elevated serum kynurenine at 24, 48 and 72 h. Brain kynurenic acid and quinolinic acid were significantly increased at 24 and 48 h in mice receiving LPS + LPS, whereas serum kynurenic acid levels were significantly decreased at 24 h. The increase of brain kynurenic acid by LPS + LPS was likely unrelated to the higher total dose as a separate group of mice receiving 1.66 mg/kg LPS as single injection 24 h prior to sacrifice did not show increased brain kynurenic acid. Serum quinolinic acid levels were not affected by LPS + LPS compared to vehicle. Animals given repeated injections of LPS showed a more robust induction of the kynurenine pathway in contrast to animals receiving a single injection. These results may be valuable in light of data showing the importance of the kynurenine pathway in psychiatric disorders.

Entities:  

Keywords:  Kynurenic acid; Kynurenine pathway; Lipopolysaccharide; Neuroinflammation; Psychiatric disorders; Quinolinic acid

Mesh:

Substances:

Year:  2016        PMID: 27165635     DOI: 10.1007/s11064-016-1939-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  70 in total

1.  Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia.

Authors:  José Borrell; José Miguel Vela; Angel Arévalo-Martin; Eduardo Molina-Holgado; Carmen Guaza
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

2.  Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation.

Authors:  Caroline André; Anne-Laure Dinel; Guillaume Ferreira; Sophie Layé; Nathalie Castanon
Journal:  Brain Behav Immun       Date:  2014-03-27       Impact factor: 7.217

3.  Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.

Authors:  Amy C Chess; David J Bucci
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

4.  Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.

Authors:  Floor van Heesch; Jolanda Prins; Jan Pieter Konsman; Gerdien A H Korte-Bouws; Koen G C Westphal; Joanna Rybka; Berend Olivier; Aletta D Kraneveld; S Mechiel Korte
Journal:  Eur J Pharmacol       Date:  2014-01-17       Impact factor: 4.432

5.  Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: Possible role of activation of the central amygdala.

Authors:  Ryota Haba; Norihito Shintani; Yusuke Onaka; Hyper Wang; Risa Takenaga; Atsuko Hayata; Akemichi Baba; Hitoshi Hashimoto
Journal:  Behav Brain Res       Date:  2011-12-24       Impact factor: 3.332

6.  Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase.

Authors:  S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  Acute systemic LPS-mediated inflammation induces lasting changes in mouse cortical neuromodulation and behavior.

Authors:  Z Ming; G Sawicki; L K Bekar
Journal:  Neurosci Lett       Date:  2015-02-01       Impact factor: 3.046

8.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

9.  Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

Authors:  Daniel Lindqvist; Shorena Janelidze; Peter Hagell; Sophie Erhardt; Martin Samuelsson; Lennart Minthon; Oskar Hansson; Maria Björkqvist; Lil Träskman-Bendz; Lena Brundin
Journal:  Biol Psychiatry       Date:  2009-03-06       Impact factor: 13.382

10.  Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice.

Authors:  Cécile Mormède; Karine Palin; Keith W Kelley; Nathalie Castanon; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2004-03       Impact factor: 7.217

View more
  13 in total

1.  Maternal immune activation in rats blunts brain cytokine and kynurenine pathway responses to a second immune challenge in early adulthood.

Authors:  Sarah M Clark; Francesca M Notarangelo; Xin Li; Shuo Chen; Robert Schwarcz; Leonardo H Tonelli
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-09-27       Impact factor: 5.067

2.  Quantitative Analysis of Kynurenine Aminotransferase II in the Adult Rat Brain Reveals High Expression in Proliferative Zones and Corpus Callosum.

Authors:  Chang Song; Sarah M Clark; Chloe N Vaughn; James D Nicholson; Kelley J Murphy; Ta-Chung M Mou; Robert Schwarcz; Gloria E Hoffman; Leonardo H Tonelli
Journal:  Neuroscience       Date:  2017-11-08       Impact factor: 3.590

3.  LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning.

Authors:  A Oliveros; K Wininger; J Sens; M K Larsson; X C Liu; S Choi; A Faka; L Schwieler; G Engberg; S Erhardt; D S Choi
Journal:  J Neuroimmunol       Date:  2017-09-28       Impact factor: 3.478

4.  Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice.

Authors:  Pablo Giménez-Gómez; Mercedes Pérez-Hernández; Esther O'Shea; Javier R Caso; David Martín-Hernandez; Luis Alou Cervera; María Luisa Gómez-Lus Centelles; María Dolores Gutiérrez-Lopez; Maria Isabel Colado
Journal:  FASEB J       Date:  2019-09-11       Impact factor: 5.191

5.  Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse.

Authors:  Amy G Brown; Natalia M Tulina; Guillermo O Barila; Michael S Hester; Michal A Elovitz
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

6.  Time and frequency dependent changes in resting state EEG functional connectivity following lipopolysaccharide challenge in rats.

Authors:  Matthew A Albrecht; Chloe N Vaughn; Molly A Erickson; Sarah M Clark; Leonardo H Tonelli
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

7.  Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation.

Authors:  Min-Jung You; Minji Bang; Hyun-Sun Park; Bohyun Yang; Kyu Beom Jang; Jongman Yoo; Dong-Youn Hwang; MinYoung Kim; Borah Kim; Sang-Hyuk Lee; Min-Soo Kwon
Journal:  Transl Psychiatry       Date:  2020-04-27       Impact factor: 6.222

8.  A single prenatal lipopolysaccharide injection has acute, but not long-lasting, effects on cerebral kynurenine pathway metabolism in mice.

Authors:  Francesca M Notarangelo; Robert Schwarcz
Journal:  Eur J Neurosci       Date:  2021-08-17       Impact factor: 3.698

9.  Anti-inflammatory effects of minocycline are mediated by retinoid signaling.

Authors:  Vera Clemens; Francesca Regen; Nathalie Le Bret; Isabella Heuser; Julian Hellmann-Regen
Journal:  BMC Neurosci       Date:  2018-09-21       Impact factor: 3.288

10.  Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing.

Authors:  Jonghee Hong; Minji Bang
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.